Cutler Group’s Ambrx Biopharma Inc AMAM Stock Holding History

Cutler Group’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300	Closed	-$1K	–	3943
2023 Q4	$1K	Sell	300 -8,800	-97%	-$100K	﹤0.01%	3526
2023 Q3	$21K	Sell	9,100 -17,000	-65%	-$232K	﹤0.01%	2014
2023 Q2	$65K	Buy	26,100 +14,300	+121%	+$180K	0.01%	1160
2023 Q1	$17K	Buy	11,800 +2,400	+26%	+$12.1K	﹤0.01%	2025
2022 Q4	$2K	Buy	+9,400	New	+$10.7K	﹤0.01%	3845

Cutler Group's AMAM Position: Q1 2024 in Review

Cutler Group sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 2,380 shares — an estimated $33K sold.

Cutler Group first reported a position in AMAM in Q4 2022 and held it in 5 quarters. The position peaked at $33K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Cutler Group reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 2,380 Ambrx Biopharma Inc shares in Q1 2024, an estimated $33K.
Cutler Group first reported a position in Ambrx Biopharma Inc in Q4 2022 and held it in 5 quarters.
Cutler Group's Ambrx Biopharma Inc position peaked at $33K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.